William D. Figg
13Patents
3h-index
38Co-inventors
56Inventor score
Filing activity: Feb 26, 2002 → Oct 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7973057B2 | Thalidomide analogs | Chemistry; Metallurgy | 21 | Active |
| US8716315B2 | Analogs of thalidomide as potential angiogenesis inhibitors | Chemistry; Metallurgy | 9 | Active |
| US7320991B2 | Analogs of thalidomide as potential angiogenesis inhibitors | Chemistry; Metallurgy | 8 | Expired |
| US10836721B2 | Thalidomide analogs and methods of use | Chemistry; Metallurgy | 1 | Active |
| US8853253B2 | Thalidomide analogs | Electricity | 0 | Active |
| US8835115B2 | ABCB1 genotyping to predict microtubule-stabilizing-agent-induced toxicity | Chemistry; Metallurgy | 0 | Active |
| US10246463B2 | Hypoxia-inducible factor 1 (HIF-1) inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8546430B2 | Thalidomide analogs | Chemistry; Metallurgy | 0 | Active |
| US11440880B2 | Thalidomide analogs and methods of use | Chemistry; Metallurgy | 0 | Active |
| US8143252B2 | Tetrahalogenated compounds useful as inhibitors of angiogenesis | Chemistry; Metallurgy | 0 | Active |
| US10094836B2 | SLCO1B3 genotype | Chemistry; Metallurgy | 0 | Active |
| US10730835B2 | Thalidomide analogs and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9676788B2 | Aza-epoxy-guaiane derivatives and treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.